Mirae Asset Global Investments Co., Ltd. Ani Pharmaceuticals Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 700 shares of ANIP stock, worth $38,157. This represents 0.0% of its overall portfolio holdings.
Number of Shares
700
Previous 761
8.02%
Holding current value
$38,157
Previous $45,000
15.56%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ANIP
# of Institutions
211Shares Held
19.2MCall Options Held
3.4KPut Options Held
10.8K-
Black Rock Inc. New York, NY2.66MShares$145 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$71.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1MShares$54.7 Million0.03% of portfolio
-
State Street Corp Boston, MA737KShares$40.2 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY700KShares$38.1 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $950M
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...